U.S., May 19 -- ClinicalTrials.gov registry received information related to the study (NCT07594262) titled 'NET-TIME: Inflammatory Tumor Microenvironment in Pituitary Neoplasm' on Sept. 19, 2024.
Brief Summary: Over the past twenty years, a progressively increasing number of markers biochemical, clinical, imaging, histopathological or genetic have been suggested to attempt to predict aggression and therapeutic outcome, both in secretory PitNETs and in non-secretory PitNETs. In recent years, the microenvironment tumor (TEM) has been extensively studied in different malignancies, promoting the development of therapies target and immunotherapy with checkpoint inhibitors immune system (ICI). Data on TIME in PitNETs are scarce today and derive ...